Neo Ivy Capital Management’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-47,748	Closed	-$308K	–	309
2023 Q2	$308K	Buy	+47,748	New	+$308K	0.16%	190
2022 Q4	$235K	Buy	23,178 +21,026	+977%	+$213K	0.16%	213
2022 Q3	$21K	Buy	+2,152	New	+$21K	0.06%	289